Non-small cell lung cancer targeted nanoparticles with reduced side effects fabricated by flash nanoprecipitation

Non-small cell lung cancer targeted nanoparticles with reduced side effects fabricated by flash nanoprecipitation

Abstract Background Tyrosine kinase inhibitors (TKI) have been highlighted for the therapy of non-small-cell lung cancer (NSCLC), due to their capability of efficiently blocking signal pathway of epidermal growth factor receptor (EGFR) which causes the inhibition and apoptosis of NSCLC cells. Howeve...

Full description

Bibliographic Details
Main Authors: Mingwei Wang, Haiyan Huang, Zilong Zhong, Xinyue Chen, Yuan Fang, Shenxin Chen, Zhiyao Qi, Danrong Yang, Junyou Wang, Wei Bian
Format: Article
Language:English
Published: BMC 2023-05-01
Series:Cancer Nanotechnology
Subjects:
NSCLC
Flash nanoprecipitation
Drug-loaded nanoparticles
Targeting delivery
Tyrosine kinase inhibitors
Reduced side effects
Online Access:https://doi.org/10.1186/s12645-023-00199-2

Internet

https://doi.org/10.1186/s12645-023-00199-2

Similar Items